NASDAQ · Price History

Apnimed, Inc. (APMD) Stock Price History & Returns

$17.80 NASDAQ: APMD Market Cap $741.03M

Price history through Nov 17, 2026 · Source: Yahoo Finance (adjusted closes) (methodology)

How Apnimed, Inc. (APMD) has performed, year by year and over each trailing period. Price history only — total return to a shareholder would also include dividends.

The share price of $17.80 sits 18% of the way up a 52-week range of $13.88 to $35.29; 49.6% below the 52-week high; below its 50-day moving average of $20.29; below its 200-day average of $22.92; a beta of 7.95 means it has historically moved more than the market.

Total return

Price change over each trailing period, not annualised.

PeriodReturn
3 months-45.5%

Monthly closing prices

The last 5 months, newest first. 2 of 4 months closed higher than the month before. Each figure is the last close in that month.

MonthCloseChange
November 2026$17.80+8.5%
October 2026$16.41-25.2%
September 2026$21.95-16.5%
August 2026$26.28+6.4%
July 2026$24.69—

Apnimed, Inc. (APMD) price history — frequently asked questions

How has Apnimed, Inc. performed over the last year?

Apnimed, Inc. (APMD) has risen 0.0% over the last twelve months, measured on price alone.

What is Apnimed, Inc.'s five-year return?

Over five years the APMD share price has gained 0.0%, excluding dividends.

What is Apnimed, Inc.'s 52-week range?

Over the last year Apnimed, Inc. (APMD) has traded between $13.88 and $35.29.

Price returns of other Biotechnology stocks

VRTX 1-year +22.4%REGN 1-year +38.2%MRNA 1-year +740.3%RVMD 1-year +137.0%ROIV 1-year +92.3%INSM 1-year -36.3%UTHR 1-year +27.9%INCY 1-year +14.8%ALNY 1-year -63.6%ASND 1-year +33.4%All Biotechnology stocks

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNasdaq High ROE StocksAll stock screens

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.